Initial United States clinical and pharmacologic evaluation of misonidazole (Ro-07-0582), an hypoxic cell radiosensitizer
- 30 June 1979
- journal article
- clinical trial
- Published by Elsevier in International Journal of Radiation Oncology*Biology*Physics
- Vol. 5 (6), 775-786
- https://doi.org/10.1016/0360-3016(79)90061-0
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Determination of metronidazole and misonidazole and their metabolites in plasma and urine by high-performance liquid chromatographyJournal of Chromatography B: Biomedical Sciences and Applications, 1978
- Hypoxic cell sensitisers in radiotherapyInternational Journal of Radiation Oncology*Biology*Physics, 1978
- Differential cytotoxic effects of metronidazole and other nitro-heterocyclic drugs against hypoxic tumour cellsInternational Journal of Radiation Oncology*Biology*Physics, 1978
- Radiosensitization of solid tumors by nitroimidazolesInternational Journal of Radiation Oncology*Biology*Physics, 1978
- Once a week treatmentsInternational Journal of Radiation Oncology*Biology*Physics, 1977
- Ro-07-0582 as a radiosensitizer and cytotoxic agentInternational Journal of Radiation Oncology*Biology*Physics, 1977
- An investigation of the radiosensitizing effects of RO-07-0582 on hypoxic skin in primatesInternational Journal of Radiation Oncology*Biology*Physics, 1976
- Radiation and High-Dose Metronidazole in Supratentorial GlioblastomasNew England Journal of Medicine, 1976
- Clinical testing of the radiosensitiser Ro-07-0582 I. dose tolerance, serum and tumour concentrationsClinical Radiology, 1976
- Radiosensitization of anoxic cells by metronidazoleThe British Journal of Radiology, 1973